Nod-Like Receptors: Cytosolic Watchdogs for Immunity against Pathogens by Sirard, Jean-Claude et al.
Review
Nod-Like Receptors: Cytosolic Watchdogs
for Immunity against Pathogens
Jean-Claude Sirard, Ce ´cile Vignal, Rodrigue Dessein, Mathias Chamaillard
*
ABSTRACT
I
n mammals, tissue-speciﬁc sets of pattern-recognition
molecules, including Nod-like receptors (NLR), enable
concomitant and sequential detection of microbial-
associated molecular patterns from both the extracellular and
intracellular microenvironment. Repressing and de-
repressing the cytosolic surveillance machinery contributes
to vital immune homeostasis and protective responses within
speciﬁc tissues. Conversely, defective biology of NLR drives
the development of recurrent infectious, autoimmune and/or
inﬂammatory diseases by failing to mount barrier functions
against pathogens, to tolerate commensals, and/or to instruct
the adaptive immune response against microbes. Better
decoding microbial strategies that are evolved to circumvent
NLR sensing will provide clues for the development of
rational therapies aimed at curing and/or preventing
common and emerging immunopathologies.
Introduction
Mammals face life-threatening signals and have the double-
edged challenge of eliminating infectious agents and
tolerating their ﬂora, especially in the gastrointestinal tract.
In mammals, the combination of germ-line encoded pattern-
recognition molecules (PRM), including Toll-like receptors
(TLR) and Nod-like receptors (NLR), plays an essential role in
detecting a diversiﬁed set of extracellular and intracellular
‘‘danger’’ signals that primarily originate from microbes (so-
called microbial-associated molecular patterns [MAMP]) [1,2].
MAMP are highly conserved microbial-derived molecules
shared by both pathogens (in which they are designated as
PAMP [pathogen-associated molecular patterns]) and
commensals, such as lipopolysaccharides, carbohydrates
(including peptidoglycans [PGN]), ﬂagellins, nucleic acids,
and peptidic and lipidic structures [3]. Originally identiﬁed in
the fruit ﬂy and plants, the membrane-bound receptors TLR
sense MAMP through their extracellular domain, whereas
NLR detect signals inside the cells. Upon recognition of their
speciﬁc MAMP (Table 1), NLR drive innate and adaptive
responses and participate in homeostasis within various host
tissues through the activation of transcription factors and
downstream effectors, such as mitogen-activated protein
kinase (MAPK) (Figure 1) [4–9]. Recent studies emphasized
major contributions of NLR in microbial pathogenesis and
mammalian immunity. Herein, we summarize the
mechanisms of microbial detection by NLR, the NLR-
mediated immune signaling, the crosstalk between NLR–NLR
and NLR–TLR in mammals, and the strategies used by
pathogens to circumvent NLR signaling. Lastly, we will discuss
the pathophysiological implications of both NLR and TLR in
human diseases, because mutations in NLR- and TLR-
encoding genes have been linked to chronic inﬂammatory
diseases, resistance and susceptibility toward a panel of
infectious agents, and/or autoimmunity.
NLR Are Cytosolic Biosensors for Both Intra- and
Extracellular Microbes
Similarly to the superfamily of plant disease-resistance
proteins [10], the structure of NLR, also referred as
caterpillers, is composed of a N-terminal effector domain, a
central oligomerization domain (called NACHT for neuronal
apoptosis inhibitor protein, CIITA, HET-E, and TP1), and a
C-terminal collection of leucine-rich repeats (LRR) [4–7]. A
set of about 23 mammalian NLR has been recently identiﬁed
by in silico mining of genomic databases for proteins with
homology to the apoptosis regulator Apaf-1. NLR are
classiﬁed accordingly to their effector domains, caspase-
recruitment domain (CARD) for nucleotide-binding
oligomerization domain protein (NOD), the pyrin domain
(PYD) for NALP, and the baculovirus-inhibitor-of-apoptosis
repeats (BIR) for NAIP (Figure 1 and Table 1). The effector
modules CARD and PYD belong to the death-domain family
and deﬁne the speciﬁcity of the cellular response by
activating multiple signaling pathways through homophilic
and heterophilic protein-protein association.
The NOD-dependent signaling pathway. Bacterial PGN is a
parietal structure found in all proteobacteria, and both
NOD1 and NOD2 have been identiﬁed as sensors of
fragments derived from PGN, namely muramyl dipeptide
(MDP) for NOD2 [11–13] and c-D-Glu-meso-DAP (iE-DAP) for
NOD1 [14,15]. Upon recognition of MDP or iE-DAP, the
CARD-containing serine/threonine kinase RIP2 (also known
as RICK, CARDIAK, CCK, and Ripk2) engages inﬂammatory
and antimicrobial responses independently of TLR [16–18].
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triggered by invasive bacteria that replicate inside cells, such
as Listeria monocytogenes [16,17,19] (Figure 1). Whereas RIP2-
deﬁcient mice have increased susceptibility to systemic
infection by L. monocytogenes [18], NOD2-deﬁcient mice
showed susceptibility to oral (but not systemic) listeriosis [13].
Extracellular bacterial pathogens can also be sensed by NOD1
and NOD2 through the intracellular delivery of
muropeptides by either their type III or IV secretion
apparatus [20,21]. These secretion machines are molecular
syringes that form transport channels through the membrane
of target cells to deliver virulence factors into cytosol.
However, the mechanisms by which muropeptides are
injected intracellularly remain elusive. Notably, NOD1 is
required for the innate immune response to Helicobacter pylori,
a major agent of gastric ulcer [20]. Conversely, bacterial
mutants deﬁcient in PGN synthesis or type IV secretion
system have impaired ability to trigger NOD1-mediated
responses in epithelial cells of the stomach [20,22].
More recently, CARD9 has been identiﬁed to physically
interact with NOD2 and RIP2 to selectively synergize the
MDP-induced activation of MAPK but not of nuclear factor–j
B (NF-jB) (Figure 1), providing a mechanism by which
CARD9 might control innate immune response toward
intracellular pathogens [23]. CARD9 is a CARD-containing
adaptor which modulates the development of T(H)-17
response [24] and lacks the C-terminal, membrane-associated
guanylate kinase domain. Similarly to RIP2-deﬁcient mice,
CARD9-deﬁcient mice are susceptible to systemic infections
by L. monocytogenes [23]. Because CARD9 is involved in
Dectin1-mediated response to fungal infection [25], the
physiological role of NOD1 and NOD2 in response to fungi is
now eagerly awaited. Lastly, given that CARD9 is also
required for TLR3- and TLR7-dependent signaling pathways
[23], further work is now warranted to assess the physiological
role of CARD9 in immunity to viruses.
The inﬂammasome. The inﬂammasome is an inﬂammatory
caspase-activating complex, which contain at least caspase-1
and -5, ASC, NALP1-3, IPAF, and NAIP5 [26]. Notably,
caspase-5 is recruited by NALP1, but not NALP2 and NALP3,
through homophilic CARD–CARD interactions (Figure 1)
[26,27]. However, the physiological role of NALP2 and
caspase-5 remains poorly understood [28]. Caspase-1, also
known as IL-1–converting enzyme (ICE), is a protease
involved in pyroptosis, a recently described form of
inﬂammatory programmed cell death, and is essential for the
processing of immature pro-inﬂammatory cytokine IL-1b and
the related members IL-1a, IL-18, and IL-33 [29]. The IL-1b is
instrumental to initiate and/or amplify innate and adaptive
immunity toward pathogens [28]. Caspase-1 activation is also
involved in the cleavage of the MyD88-like adaptor Mal [30]
and in membrane biogenesis by promoting cell survival
following toxin-induced membrane permeabilization [31].
The contribution of caspase-1 and NALP/NAIP in host–
pathogen interaction has been analyzed in vivo by using
animal models of infection or in vitro by using cytokine and
viability assays with monocytes/macrophages. Caspase-1
 / 
mice, which are inoculated nasally by the agent of bacillary
dysentery Shigella ﬂexneri cannot trigger IL-1b–dependent
acute inﬂammation, thereby resulting in exacerbated
doi:10.1371/journal.ppat.0030152.g001
Figure 1. Intracellular Debugging of the NLR Signaling Pathways
A schematic overview of the major NLR signaling pathways in innate immunity is depicted. Upon detection of their agonists, NLR likely oligomerize
through the NOD domain and recruit at least three specific adaptors, including RIP2, CARD9, and ASC. Several modulators of NLR signaling have been
recently identified, such as Erbin, Bcl2, and Bcl-xl. The maturation of IL-1b by the inflammasome illustrates the interplay between NLR (i.e., NALP1–3,
NAIP5, and IPAF) and other PRM, such as TLR. Better understanding of the spatio-temporal engagement and/or repression of specific NLR might open
new avenues for therapeutical intervention.
PLoS Pathogens | www.plospathogens.org December 2007 | Volume 3 | Issue 12 | e152 1831infection [32]. Interestingly, a positive correlation was deﬁned
for S. Typhimurium and S. ﬂexneri between their capacity to
promote macrophage death and their virulence in mice. This
effect has been proposed to depend on the inﬂammasome
[26,33].
Sensing of several extracellular and intracellular
pathogenic bacteria is associated to the secretion of IL-1b by
activating caspase-1 through at least ﬁve NLR, namely ICE
protease-activating factor (IPAF), NALP-1,  2 and  3, and
NAIP5 (Figure 1 and Table 1). Containing a N-terminal PYD
and a C-terminal CARD, the death-fold–containing adaptor
apoptosis-associated speck-like protein containing a CARD
(ASC) acts as a molecular bridge between NALP1-3, IPAF, and
caspase-1 [26] (Figure 1). In vivo, NALP1 senses the Bacillus
anthracis lethal toxin, which is delivered in the cytoplasm by
receptor-mediated endocytosis [34]. The bacterial PGN
component MDP activates both the NALP1- and NALP3-
dependent inﬂammasome [35,36]. NALP3 is also able to
detect a large variety of additional microbial signals (such as
microbial RNA) and cytolytic toxins (such as aerolysin from
Aeromonas hydrophila and maitotoxin) [31,37–39]. The NALP3-
dependent inﬂammasome is also activated by cellular
components that are released into the extracellular milieu by
distressed cells such as crystals found in gout, namely
monosodium urate and calcium pyrophosphate dihydrate
[40]. Oral infection with S. Typhimurium of caspase-1–
deﬁcient mice, but not ASC
 / , NALP3
 / , or IPAF
 /  animals,
leads to increased susceptibility to infection [41]. Similar
observations have been reported with L. monocytogenes [42,43].
Furthermore, caspase-1– and ASC-deﬁcient (but not IPAF-
and NOD2-deﬁcient) mice experienced increased
susceptibility to Francisella tularensis, the agent of tularemia
[44].
By using microinjection or liposome delivery or bacterial
mutants, the caspase-1 activators, such as IpaB (from S.
ﬂexneri), SipB (from S. Typhimurium) and ﬂagellin (from S.
Typhimurium and Legionella pneumophila), have been recently
proposed to signal through NAIP5 and IPAF [45–50].
Interestingly, NAIP5 is required to limit the maturation of
phagosomes following in vitro infection by L. pneumophila, the
agent of Legionnaires disease, [51] and restrict its
intracellular replication independently of caspase-1
activation [49,52]. IPAF has similar functions that depend,
however, on caspase-1 [52,53]. Notably, IPAF and caspase-1,
but not ASC, are required to control pyroptosis and
autophagy induced by Shigella independently of ﬂagellin [54].
Whereas NAIP5 confers resistance to Legionnaires disease
[55–57], the physiological role of IPAF remains elusive with
respect to L. pneumophila. Unlike the inﬂammasome, the
sensing of ﬂagellin through TLR5 does not trigger caspase-1
activation, suggesting that IPAF and NAIP5 represent a fail-
safe immune mechanism to respond to ﬂagellated pathogens
[48,57,58]. Lastly, interferon-b and tumor necrosis factor-a
have been implicated in restricting the growth of L.
pneumophila in macrophages, but independently of IPAF and
NAIP5 [49,59]. Taken together, deﬁciency in NAIP5, ASC,
and/or caspase-1 in mice are, instead, associated with
increased susceptibility to invasive microbes and with
resistance to the lethal effect of endotoxins [50,60].
Therefore, the NLR signaling pathway and the inﬂammasome
represent ‘‘watchdog’’ machineries against both intra- and
extracellular pathogens, including toxicogenic microbes.
Optimal Immune Response Toward Pathogens
Requires NLR
Given that several sensors are likely solicited when host cell
faces a microorganism, the engagement of speciﬁc
combinations of NLR and other PRM affect the host response
by driving either tolerance, priming, or synergy. Notably, by
using cell-based assays, it was found that chemically
synthesized NOD1 and NOD2 agonists synergize TLR-
dependent cytokines expression in monocytes [61–66].
Similar ﬁndings have been reported in dendritic cells (DCs)
for the secretion of IL-12 [67,68], which is a major cytokine
produced by DCs to promote T(H)1 polarization of T cells
[69]. DCs are the central ‘‘professional’’ immune cells for the
initiation of the adaptive immunity by activating the T
lymphocyte differentiation into T(H)1 or T(H)2 cells. It is
worth noting that the RIP2 signaling pathway is required for
efﬁcient elicitation of antigen-speciﬁc T and B cell immunity
and for instructing subsequently the onset of T(H)1 and
T(H)2, as well as T(H)17 immune pathways by regulating IL-
23, IL-12, interferon-c and IL-17 [13,18,70]. Conversely,
NOD1- and NOD2-deﬁcient bone marrow–derived
macrophages and macrophages bearing loss-of-function of
NOD2 failed to synergize the expression of inﬂammatory
cytokines following concomitant stimulation by NOD1/2 and
TLR agonists [13,14,63]. The role of the inﬂammasome in the
development of autoimmune diseases and T(H)17 response to
pathogens and ‘‘danger’’ signals remains to be further
documented, because the IL-1 receptor is required to drive
the development of experimental autoimmune
encephalomyelitis and the production of IL-17 [71,72].
Triggering of a speciﬁc PRM induces a transient
phenomenon of tolerance and/or cross-tolerance toward a
second stimulation by the same agonist [73]. This
unresponsiveness window may be essential to protect the host
from sustained innate response. If a microorganism colonizes
a TLR-responsive niche, one can expect that the TLR
signaling might be exhausted. This TLR refractory state is
nevertheless speciﬁc for this niche and for a certain period of
time. In this context, subsequent signaling is likely to occur
for unrepressed NLR signaling pathways [74,75].
Alternatively, sequential engagement of distinct TLR
stimulates mainly the synergistic production of pro-
inﬂammatory mediators [73]. Therefore, systematic dissection
of the synergy and tolerance induced by TLR and/or NLR is
now warranted for rationale therapeutic intervention.
The heterotypic interactions between NLR have also been
proposed to regulate their function [76,77], as well as
interplay with additional proteins like Erbin for the NOD2
signaling pathway [78]. Effective NALP1- and NALP3-
dependent inﬂammasome activation requires both the
synthesis of pro-IL-1b and several incoming signals.
Activation of TLR signaling pathways has often been used as a
ﬁrst signal that drives the expression of the IL-1b–encoding
gene [47–49,58,79–81]. Activation of caspase-1 and release of
mature IL-1b might then result from the cytosolic detection
by the inﬂammasome of a second signal (which are primarily
microbial compounds and self-danger signals). Alternatively,
the intracellular concentration of potassium and ATP/dATP,
which might be modulated by toxins and pathogens, control
inﬂammasome activation [80,82–84]. In this context, the
transmembrane receptor Pannexin-1 and the P2X(7) receptor
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transferring bacterial components from outside to the cytosol
[80]. It is worth noting the increased viability of ‘‘permissive’’
macrophages to replication of L. pneumophila, which is in part
explained by a speciﬁc targeting of pro-death members of the
Bcl2 protein family [85]. Similarly to what occurs in the
nematode Caenorhabditis elegans, a complex interplay between
cell survival and caspase-1 activation has been recently
unraveled, as the mammalian anti-apoptotic proteins Bcl-2
and Bcl-Xl repress speciﬁcally the NALP1-mediated caspase-1
activation [35]. Implications for the pathophysiology of
human inﬂammatory diseases and the pathogenesis of
pathogens that activate caspase-1, like L. pneumophila, remain
to be investigated for the development of rational
prophylactic and anti-infectious therapies.
NLR in Antimicrobial Immunity
Antimicrobial peptides, such as defensins, play an active
role in fortifying the lining of the gut toward pathogens and
commensals by preserving epithelium integrity and stem cell
viability and by participating in the recruitment of
immunocytes. Defensins are cationic antimicrobial peptides
rich in cysteine residues that exert their activity by damaging
the bacterial cell wall [86]. Mammalian defensins can be
divided into two main subsets, the a and b defensins. In
humans, a defensins 1–4 are produced by neutrophils and are
stored in granules, whereas a defensins 5 and 6 (referred as
cryptdins in mice) are mostly secreted by Paneth cells in the
lumen of the small intestine. The human b defensins are more
widely expressed and are synthesized by most of the epithelia.
Proteases (e.g., trypsin and metalloproteinase-7) play an
essential role in the maturation process of defensins [87,88].
Alternatively, the expression of certain antimicrobial peptide-
encoding genes is down-regulated during shigellosis in
humans and salmonellosis in mice [89,90]. In this context, we
might speculate that speciﬁc combinations of PRM coordinate
a three-steps immune response by regulating expression,
degranulation, and maturation of antimicrobial peptides.
Recent evidences shed also lights on a nonredundant role
of NLR and TLR in the differential expression and
maturation of speciﬁc sets of antimicrobial peptides [91]. By
using cell lines, NOD1 and NOD2 agonists have been shown
to up-regulate the expression of the human b defensin-2
(hBD2)–encoding gene [91]. Likewise, inhibition of the NF-jB
pathway totally blocks NOD1- and NOD2-dependent
induction of hBD2 expression, whereas inhibition of p38 and
JNK signaling pathways only partially diminish hBD2
expression in a NOD1-dependent manner [22,92].
Consistently, MDP-induced hBD2 expression was down-
regulated after knocking down NOD2 or by transfecting
HEK293 cells with the Crohn disease–associated 3020insC
frameshift mutation [92]. In vivo, TLR5-deﬁcient mice exhibit
impaired expression of mouse b defensin-3 (the homolog of
the hBD-2) by intestinal epithelial cells [93], whereas NOD1-
and NOD2-deﬁcient mice showed a deﬁciency in mouse b
defensin-4 by gastric epithelial cells and in certain cryptdins
by Paneth cells, respectively [13,22]. Combining experiments
using mice and human models might shed light on the
potential effect of antimicrobial peptides in response to
speciﬁc infectious agents and in the control of physiological
inﬂammation.
Microbial Alteration of NLR Sensing and Signaling
Pathogens have also evolved strategies to circumvent their
intracellular sensing through NLR such as NOD1 by
preventing processing and optimal sensing of their PGN.
Indeed, a L. monocytogenes–derived deacetylase, namely PgdA,
is required to bypass the early innate immune response of
NOD1 by speciﬁcally adding N-acetylglucosamine residues to
the DAP-type PGN. pgdA mutants triggered sensitivity to the
bacteriolytic activity of lysozyme, leading to increased NOD1-
dependent interferon-b immune response and have impaired
virulence in vivo [94]. Similarly, the PGN hydrolase AmiA is
involved in the microbial pathogenesis of H. pylori by limiting
the sensing by NOD1 [95]. The implications of post-
translational changes of additional MAMP, including MDP, in
microbial pathogenesis remain to be systematically
investigated.
Commensal and symbiotic microorganisms may actively
interfere with NLR-mediated response by down-regulating
pro-inﬂammatory signaling and/or by modifying cell
differentiation/proliferation. Bacteroides thetaiotamicron
speciﬁcally stimulates the nucleus-cytosol shuttling of NF-jB
in a peroxisome proliferator–activated receptor-c–
dependent mechanism [96]. The bacterial molecules driving
this down-regulation might consequently affect NOD
signaling. In addition to commensal, pathogenic bacteria are
also able to interfere with NOD, as recently showed in Yersinia
species that block stimulation of NF-jB– and MAPK-
dependent gene expression through acetylation of MAPK
[97]. In other respects, S. ﬂexneri produces a phosphatase that
is speciﬁc for nuclear MAPK, thus preventing histone H3
modiﬁcation and NF-jB–dependent transcription of pro-
inﬂammatory genes [98]. Lastly, modiﬁcation of
ubiquitination is also a candidate mechanism for invasive
microbes to subvert sensing through NLR and is now the
subject of investigation [99]. This conceptual view of
regulation of NLR signaling now warrants further
investigation to better understand the double-edged
challenge of the mucosa toward commensals and pathogens
in health and disease.
Impaired TLR and NLR Function Are Sufficient to
Drive Human Immunopathologies
Microbial sensing deﬁciency in fruit ﬂy and mice confers
an increased susceptibility to several infectious agents and
leads to the development of autoimmune disease. In humans,
defective NF-jB– and TLR-dependent immunity have been
associated with restricted inherited infectious diseases, in
that hypomorphic or null germline mutations of TLR5,
IRAK4, NEMO, and UNC-93B are sufﬁcient for the
development of Legionnaires disease [100], recurrent
pneumococcal disease [101], mycobacterial disease [102], and
herpes simplex virus encephalitis [103], respectively.
Similarly, common infection might result primarily from
mutations in a major susceptibility gene, as impaired TLR2/
Mal signaling is conferring protection against invasive
pneumococcal disease, bacteremia, malaria, and tuberculosis
in the United Kingdom, Vietnam, and several African
countries through an increased frequency of the Ser allele at
the Mal S180L variant [104]. Hence, these observations have
challenged dogmas in the genetics of human infectious
diseases, and they might suggest that both rare and common
PLoS Pathogens | www.plospathogens.org December 2007 | Volume 3 | Issue 12 | e152 1833infectious diseases may result from defect in a major
biological pathway.
Like infectious diseases, complex inﬂammatory traits result
from the inheritance of major susceptibility alleles and the
exposure to several environmental factors. No speciﬁc
infectious agents have been identiﬁed so far, but note that
gain-of-function mutations in NALP3 [105] and NOD2 [106]
cause Mendelian inﬂammatory diseases, such as
autoinﬂammatory disorders (Muckle-Wells syndrome,
familial cold autoinﬂammatory syndrome, and chronic
infantile neurologic cutaneous and articular syndrome) and
Blau syndrome, respectively. Furthermore, predisposition to
common inﬂammatory disorders has been inextricably linked
to major susceptibility genes, as loss-of-function mutations in
TLR5 and NOD2 are protecting and predisposing,
respectively, to the development of systemic lupus
erythematosus [107] and inﬂammatory bowel diseases
[108,109]. Similarly, NEMO deﬁciency in enterocytes leads to
the spontaneous development of colitis in mice by
compromising tissue repair, epithelium integrity and
promoting bacterial translocation [110]. A missense mutation
(L155H) and noncoding polymorphism of the NALP1-
encoding gene are predisposing to the development of
vitiligo-associated multiple autoimmune disease [111],
implicating innate immunity in the pathogenesis of
autoimmunity. However, the constitutive and bacterial-
induced level of caspase-1 activation remains elusive in cells
bearing the NALP1 L155H mutation. Lastly, mutations in the
gene encoding for NALP7 cause familial and recurrent
hydatidiform moles [112–114], which are tumors that forms
in the uterus as a mass of cysts resembling a bunch of grapes.
Unlike NALP1-3, IPAF, and NAIP5, NALP7 is a negative
regulator of IL-1b signaling [115] that promotes
tumorigenesis [116]. Further work should now determine the
following: (a) how the NALP7 signaling pathway might be
activated, (b) whether NALP7 might interfere with additional
PRM, and (c) whether NALP7 might regulate innate and
adaptive immunity.
Concluding Remarks
Whereas most studies have focused on the characterization
of individual PRM, the physiological situation is more
complex, because host cells have to integrate multiple
incoming signals from damaged cells and pathogenic and
symbiotic microbes into vital immunological information. In
this context, organ-speciﬁc onset of innate and adaptive
immunity is regulated differentially by multiple cross-talks
between a limited set of functional PRM signaling
pathways. &
Acknowledgments
We apologize to our colleagues whose work was not cited here owing
to space limitations. We thank Florent Sebbane for critical reading of
the manuscript.
Author contributions. JCS, CV, RD, and MC wrote the manuscript.
Funding. JCS is supported by INSERM, the Institut Pasteur de Lille,
the Re ´gion Nord Pas de Calais and FEDER (ARCir e ´mergence), the
European Community (STREP grant VaccTIP LSHP-CT-2005-012161
SavinMucoPath INCO-CT-2006-032296), and the Franco-Argenti-
nean ECOS-SETCIP program (A04B03). CV is supported by the
Fondation pour la Recherche Me ´dicale. MC is supported by grants
from INSERM, the Re ´gion Nord Pas de Calais, the Association
Franc ¸ois AuPetit, and the IRMAD.
Competing interests. The authors have declared that no competing
interests exist.
References
1. Matzinger P (2007) Friendly and dangerous signals: is the tissue in control?
Nat Immunol 8: 11–13.
2. Raz E (2007) Organ-speciﬁc regulation of innate immunity. Nat Immunol
8: 3–4.
3. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev
Immunol 20: 197–216.
4. Tschopp J, Martinon F, Burns K (2003) NALPs: a novel protein family
involved in inﬂammation. Nat Rev Mol Cell Biol 4: 95–104.
5. Ting JP, Davis BK (2005) CATERPILLER: a novel gene family important in
immunity, cell death, and diseases. Annu Rev Immunol 23: 387–414.
6. Inohara N, Chamaillard M, McDonald C, Nunez G (2005) NOD-LRR
proteins: role in host-microbial interactions and inﬂammatory disease.
Annu Rev Biochem 74: 355–383.
7. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE (2006) Nod-like proteins in
immunity, inﬂammation and disease. Nat Immunol 7: 1250–1257.
8. Barton GM, Medzhitov R (2003) Toll-like receptor signaling pathways.
Science 300: 1524–1525.
9. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate
immunity. Cell 124: 783–801.
10. Jones JD, Dangl JL (2006) The plant immune system. Nature 444: 323–329.
11. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, et al. (2003)
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide
(MDP) detection. J Biol Chem 278: 8869–8872.
12. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. (2003) Host
recognition of bacterial muramyl dipeptide mediated through NOD2.
Implications for Crohn’s disease. J Biol Chem 278: 5509–5512.
13. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al.
(2005) Nod2-dependent regulation of innate and adaptive immunity in the
intestinal tract. Science 307: 731–734.
14. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, et al. (2003) An
essential role for NOD1 in host recognition of bacterial peptidoglycan
containing diaminopimelic acid. Nat Immunol 4: 702–707.
15. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, et al. (2003)
Nod1 detects a unique muropeptide from gram-negative bacterial
peptidoglycan. Science 300: 1584–1587.
16. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, et al. (2007)
RICK/RIP2 mediates innate immune responses induced through Nod1 and
Nod2 but not TLRs. J Immunol 178: 2380–2386.
17. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, et al. (2002)
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and
adaptive immune systems. Nature 416: 194–199.
18. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, et al. (2002) Involvement
of receptor-interacting protein 2 in innate and adaptive immune
responses. Nature 416: 190–194.
19. O’Riordan M, Yi CH, Gonzales R, Lee KD, Portnoy DA (2002) Innate
recognition of bacteria by a macrophage cytosolic surveillance pathway.
Proc Natl Acad Sci U S A 99: 13861–13866.
20. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. (2004) Nod1
responds to peptidoglycan delivered by the Helicobacter pylori cag
pathogenicity island. Nat Immunol 5: 1166–1174.
21. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, et al. (2001) CARD4/
Nod1 mediates NF-kappaB and JNK activation by invasive Shigella
ﬂexneri. EMBO Rep 2: 736–742.
22. Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, et al.
(2006) Nucleotide-binding oligomerization domain-1 and epidermal
growth factor receptor: critical regulators of beta-defensins during
Helicobacter pylori infection. J Biol Chem 281: 11637–11648.
23. Hsu YM, Zhang Y, You Y, Wang D, Li H, et al. (2007) The adaptor protein
CARD9 is required for innate immune responses to intracellular
pathogens. Nat Immunol 8: 198–205.
24. Leibundgut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, et al.
(2007) Syk- and CARD9-dependent coupling of innate immunity to the
induction of T helper cells that produce interleukin 17. Nat Immunol 8:
630–638.
25. Gross O, Gewies A, Finger K, Schafer M, Sparwasser T, et al. (2006) Card9
controls a non-TLR signalling pathway for innate anti-fungal immunity.
Nature 442: 651–656.
26. Martinon F, Burns K, Tschopp J (2002) The inﬂammasome: a molecular
platform triggering activation of inﬂammatory caspases and processing of
proIL-beta. Mol Cell 10: 417–426.
27. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, et al. (2004)
NALP3 forms an IL-1beta-processing inﬂammasome with increased
activity in Muckle-Wells autoinﬂammatory disorder. Immunity 20: 319–
325.
28. Martinon F, Tschopp J (2004) Inﬂammatory caspases: linking an
intracellular innate immune system to autoinﬂammatory diseases. Cell
117: 561–574.
29. Dinarello CA (2002) The IL-1 family and inﬂammatory diseases. Clin Exp
Rheumatol 20: S1–S13.
PLoS Pathogens | www.plospathogens.org December 2007 | Volume 3 | Issue 12 | e152 183430. Miggin SM, Palsson-McDermott E, Dunne A, Jefferies C, Pinteaux E, et al.
(2007) NF-kappaB activation by the Toll-IL-1 receptor domain protein
MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci U S A
104: 3372–3377.
31. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG (2006)
Caspase-1 activation of lipid metabolic pathways in response to bacterial
pore-forming toxins promotes cell survival. Cell 126: 1135–1145.
32. Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, et al.
(2000) Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella
ﬂexneri-induced inﬂammation. Immunity 12: 581–590.
33. Mariathasan S, Monack DM (2007) Inﬂammasome adaptors and sensors:
intracellular regulators of infection and inﬂammation. Nat Rev Immunol
7: 31–40.
34. Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage
susceptibility to anthrax lethal toxin. Nat Genet 38: 240–244.
35. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, et al. (2007) Bcl-2
and Bcl-XL regulate proinﬂammatory caspase-1 activation by interaction
with NALP1. Cell 129: 45–56.
36. Martinon F, Agostini L, Meylan E, Tschopp J (2004) Identiﬁcation of
bacterial muramyl dipeptide as activator of the NALP3/cryopyrin
inﬂammasome. Curr Biol 14: 1929–1934.
37. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, et al. (2006)
Bacterial RNA and small antiviral compounds activate caspase-1 through
cryopyrin/Nalp3. Nature 440: 233–236.
38. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitﬁeld J, et al.
(2006) Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in
response to viral infection and double-stranded RNA. J Biol Chem 281:
36560–36568.
39. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, et al. (2006)
Cryopyrin activates the inﬂammasome in response to toxins and ATP.
Nature 440: 228–32.
40. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-
associated uric acid crystals activate the NALP3 inﬂammasome. Nature
440: 228–232.
41. Lara-Tejero M, Sutterwala FS, Ogura Y, Grant EP, Bertin J, et al. (2006)
Role of the caspase-1 inﬂammasome in Salmonella typhimurium
pathogenesis. J Exp Med 203: 1407–1412.
42. Ozoren N, Masumoto J, Franchi L, Kanneganti TD, Body-Malapel M, et al.
(2006) Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-18
secretion in response to Listeria monocytogenes. J Immunol 176: 4337–
4342.
43. Tsuji NM, Tsutsui H, Seki E, Kuida K, Okamura H, et al. (2004) Roles of
caspase-1 in Listeria infection in mice. Int Immunol 16: 335–343.
44. Mariathasan S, Weiss DS, Dixit VM, Monack DM (2005) Innate immunity
against Francisella tularensis is dependent on the ASC/caspase-1 axis. J
Exp Med 202: 1043–1049.
45. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, et al. (1999) The
Salmonella invasin SipB induces macrophage apoptosis by binding to
caspase-1. Proc Natl Acad Sci U S A 96: 2396–2401.
46. Chen Y, Smith MR, Thirumalai K, Zychlinsky A (1996) A bacterial invasin
induces macrophage apoptosis by binding directly to ICE. Embo J 15:
3853–3860.
47. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, et al.
(2006) Cytosolic ﬂagellin requires Ipaf for activation of caspase-1 and
interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:
576–582.
48. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, et al. (2006)
Cytoplasmic ﬂagellin activates caspase-1 and secretion of interleukin
1beta via Ipaf. Nat Immunol 7: 569–575.
49. Molofsky AB, Byrne BG, Whitﬁeld NN, Madigan CA, Fuse ET, et al. (2006)
Cytosolic recognition of ﬂagellin by mouse macrophages restricts
Legionella pneumophila infection. J Exp Med 203: 1093–1104.
50. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. (2004)
Differential activation of the inﬂammasome by caspase-1 adaptors ASC
and Ipaf. Nature 430: 213–218.
51. Fortier A, de Chastellier C, Balor S, Gros P (2007) Birc1e/Naip5 rapidly
antagonizes modulation of phagosome maturation by Legionella
pneumophila. Cell Microbiol 9: 910–923.
52. Lamkanﬁ M, Amer A, Kanneganti TD, Munoz-Planillo R, Chen G, et al.
(2007) The Nod-like receptor family member Naip5/Birc1e restricts
Legionella pneumophila growth independently of caspase-1 activation. J
Immunol 178: 8022–8027.
53. Amer A, Franchi L, Kanneganti TD, Body-Malapel M, Ozoren N, et al.
(2006) Regulation of Legionella phagosome maturation and infection
through ﬂagellin and host Ipaf. J Biol Chem 281: 35217–35223.
54. Suzuki T, Franchi L, Toma C, Ashida H, Ogawa M, et al. (2007) Differential
regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and
ASC in Shigella-infected macrophages. PLoS Pathog 3: e111. doi:10.1371/
journal.ppat.0030111
55. Diez E, Lee SH, Gauthier S, Yaraghi Z, Tremblay M, et al. (2003) Birc1e is
the gene within the Lgn1 locus associated with resistance to Legionella
pneumophila. Nat Genet 33: 55–60.
56. Wright EK, Goodart SA, Growney JD, Hadinoto V, Endrizzi MG, et al.
(2003) Naip5 affects host susceptibility to the intracellular pathogen
Legionella pneumophila. Curr Biol 13: 27–36.
57. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, et al. (2006)
The Birc1e cytosolic pattern-recognition receptor contributes to the
detection and control of Legionella pneumophila infection. Nat Immunol
7: 318–325.
58. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE (2006) Flagellin-
deﬁcient Legionella mutants evade caspase-1- and Naip5-mediated
macrophage immunity. PLoS Pathog 2: e18. doi:10.1371/journal.ppat.
0020018
59. Coers J, Vance RE, Fontana MF, Dietrich WF (2007) Restriction of
Legionella pneumophila growth in macrophages requires the concerted
action of cytokine and Naip5/Ipaf signalling pathways. Cell Microbiol 9:
2344–2357.
60. Li P, Allen H, Banerjee S, Franklin S, Herzog L, et al. (1995) Mice deﬁcient
in IL-1 beta-converting enzyme are defective in production of mature IL-1
beta and resistant to endotoxic shock. Cell 80: 401–411.
61. Takada H, Yokoyama S, Yang S (2002) Enhancement of endotoxin activity
by muramyldipeptide. J Endotoxin Res 8: 337–342.
62. Uehara A, Yang S, Fujimoto Y, Fukase K, Kusumoto S, et al. (2005)
Muramyldipeptide and diaminopimelic acid-containing
desmuramylpeptides in combination with chemically synthesized Toll-like
receptor agonists synergistically induced production of interleukin-8 in a
NOD2- and NOD1-dependent manner, respectively, in human monocytic
cells in culture. Cell Microbiol 7: 53–61.
63. van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, et al. (2005)
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated
Crohn’s disease. Lancet 365: 1794–1796.
64. van Heel DA, Ghosh S, Butler M, Hunt K, Foxwell BM, et al. (2005)
Synergistic enhancement of Toll-like receptor responses by NOD1
activation. Eur J Immunol 35: 2471–2476.
65. van Heel DA, Ghosh S, Hunt K, Mathew C, Forbes A, et al. (2005) Synergy
between TLR9 and NOD2 innate immune responses is lost in genetic
Crohn’s disease. Gut 54: 1553–1537.
66. Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, et al. (2001) Synergistic
effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid
to induce inﬂammatory cytokines in human monocytic cells in culture.
Infect Immun 69: 2045–2053.
67. Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, et al. (2005)
Synergistic stimulation of human monocytes and dendritic cells by Toll-
like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol
35: 2459–2470.
68. Tada H, Aiba S, Shibata K, Ohteki T, Takada H (2005) Synergistic effect of
Nod1 and Nod2 agonists with toll-like receptor agonists on human
dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect
Immun 73: 7967–7976.
69. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance
and adaptive immunity. Nat Rev Immunol 3: 133–146.
70. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, et al. (2007) Nod1-
mediated innate immune recognition of peptidoglycan contributes to the
onset of adaptive immunity. Immunity 26: 445–459.
71. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, et al.
(2006) Interleukin-17 is a negative regulator of established allergic asthma.
J Exp Med 203: 2715–2725.
72. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC (2006) A crucial role
for interleukin (IL)-1 in the induction of IL-17-producing T cells that
mediate autoimmune encephalomyelitis. J Exp Med 203: 1685–1691.
73. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, et al. (2007) MyD88-
dependent and MyD88-independent pathways in synergy, priming, and
tolerance between TLR agonists. J Immunol 178: 1164–1171.
74. Serbina NV, Kuziel W, Flavell R, Akira S, Rollins B, et al. (2003) Sequential
MyD88-independent and -dependent activation of innate immune
responses to intracellular bacterial infection. Immunity 19: 891–901.
75. Weiss DS, Raupach B, Takeda K, Akira S, Zychlinsky A (2004) Toll-like
receptors are temporally involved in host defense. J Immunol 172: 4463–
4469.
76. Damiano JS, Oliveira V, Welsh K, Reed JC (2004) Heterotypic interactions
among NACHT domains: implications for regulation of innate immune
responses. Biochem J 381: 213–219.
77. Mayor A, Martinon F, De Smedt T, Petrilli V, Tschopp J (2007) A crucial
function of SGT1 and HSP90 in inﬂammasome activity links mammalian
and plant innate immune responses. Nat Immunol 8: 497–503.
78. McDonald C, Chen FF, Ollendorff V, Ogura Y, Marchetto S, et al. (2005) A
role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling.
J Biol Chem 280: 40301–40309.
79. Franchi L, McDonald C, Kanneganti TD, Amer A, Nunez G (2006)
Nucleotide-binding oligomerization domain-like receptors: intracellular
pattern recognition molecules for pathogen detection and host defense. J
Immunol 177: 3507–3513.
80. Kanneganti TD, Lamkanﬁ M, Kim YG, Chen G, Park JH, et al. (2007)
Pannexin-1-mediated recognition of bacterial molecules activates the
cryopyrin inﬂammasome independent of Toll-like receptor signaling.
Immunity 26: 433–443.
81. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS,
et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and
adaptive immunity through its regulation of caspase-1. Immunity 24: 317–
327.
PLoS Pathogens | www.plospathogens.org December 2007 | Volume 3 | Issue 12 | e152 183582. Duncan JA, Bergstralh DT, Wang Y, Willingham SB, Ye Z, et al. (2007)
Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP
binding to mediate inﬂammatory signaling. Proc Natl Acad Sci U S A 104:
8041–8046.
83. Franchi L, Kanneganti TD, Dubyak GR, Nunez G (2007) Differential
requirement of P2X7 receptor and intracellular Kþ for caspase-1
activation induced by intracellular and extracellular bacteria. J Biol Chem
282: 18810–18818.
84. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, et al. (2007) Activation
of the NALP3 inﬂammasome is triggered by low intracellular potassium
concentration. Cell Death Differ 14: 1583–1589.
85. Banga S, Gao P, Shen X, Fiscus V, Zong WX, et al. (2007) Legionella
pneumophila inhibits macrophage apoptosis by targeting pro-death
members of the Bcl2 protein family. Proc Natl Acad Sci U S A 104: 5121–
5126.
86. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat
Rev Immunol 3: 710–720.
87. Ghosh D, Porter E, Shen B, Lee SK, Wilk D, et al. (2002) Paneth cell trypsin
is the processing enzyme for human defensin-5. Nat Immunol 3: 583–590.
88. Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM (1995) The
metalloproteinase matrilysin is preferentially expressed by epithelial cells
in a tissue-restricted pattern in the mouse. Mol Biol Cell 6: 851–869.
89. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, et al. (2001)
Downregulation of bactericidal peptides in enteric infections: a novel
immune escape mechanism with bacterial DNA as a potential regulator.
Nat Med 7: 180–185.
90. Salzman NH, Chou MM, de Jong H, Liu L, Porter EM, et al. (2003) Enteric
salmonella infection inhibits Paneth cell antimicrobial peptide
expression. Infect Immun 71: 1109–1115.
91. Peyrin-Biroulet L, Vignal C, Dessein R, Simonet M, Desreumaux P, et al.
(2006) NODs in defence: from vulnerable antimicrobial peptides to
chronic inﬂammation. Trends Microbiol 14: 432–438.
92. Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, et al. (2006)
NOD2/CARD15 mediates induction of the antimicrobial peptide human
beta-defensin-2. J Biol Chem 281: 2005–2011.
93. Uematsu S, Jang MH, Chevrier N, Guo Z, Kumagai Y, et al. (2006)
Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on
intestinal CD11cþ lamina propria cells. Nat Immunol 7: 868–874.
94. Boneca IG, Dussurget O, Cabanes D, Nahori MA, Sousa S, et al. (2007) A
critical role for peptidoglycan N-deacetylation in Listeria evasion from
the host innate immune system. Proc Natl Acad Sci U S A 104: 997–1002.
95. Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, et al. (2006) Role
of AmiA in the morphological transition of Helicobacter pylori and in
immune escape. PLoS Pathog 2: e97. doi:10.1371/journal.ppat.0020097
96. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, et al. (2004)
Commensal anaerobic gut bacteria attenuate inﬂammation by regulating
nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:
104–112.
97. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, et al. (2006) Yersinia YopJ
acetylates and inhibits kinase activation by blocking phosphorylation.
Science 312: 1211–1214.
98. Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, et al. (2007) An
injected bacterial effector targets chromatin access for transcription
factor NF-kappaB to alter transcription of host genes involved in immune
responses. Nat Immunol 8: 47–56.
99. Perrin AJ, Jiang X, Birmingham CL, So NS, Brumell JH (2004) Recognition
of bacteria in the cytosol of Mammalian cells by the ubiquitin system. Curr
Biol 14: 806–811.
100. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, et al. (2003) A common
dominant TLR5 stop codon polymorphism abolishes ﬂagellin signaling
and is associated with susceptibility to legionnaires’ disease. J Exp Med
198: 1563–1572.
101. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, et al. (2003) Pyogenic
bacterial infections in humans with IRAK-4 deﬁciency. Science 299: 2076–
2079.
102. Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, et al.
(2006) X-linked susceptibility to mycobacteria is caused by mutations in
NEMO impairing CD40-dependent IL-12 production. J Exp Med 203:
1745–1759.
103. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, et al. (2006)
Herpes simplex virus encephalitis in human UNC-93B deﬁciency. Science
314: 308–312.
104. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, et al. (2007) A
Mal functional variant is associated with protection against invasive
pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet
39: 523–528.
105. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001)
Mutation of a new gene encoding a putative pyrin-like protein causes
familial cold autoinﬂammatory syndrome and Muckle-Wells syndrome.
Nat Genet 29: 301–305.
106. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, et
al. (2001) CARD15 mutations in Blau syndrome. Nat Genet 29: 19–20.
107. Hawn TR, Wu H, Grossman JM, Hahn BH, Tsao BP, et al. (2005) A stop
codon polymorphism of Toll-like receptor 5 is associated with resistance
to systemic lupus erythematosus. Proc Natl Acad Sci U S A 102: 10593–
10597.
108. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to
Crohn’s disease. Nature 411: 599–603.
109. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A
frameshift mutation in NOD2 associated with susceptibility to Crohn’s
disease. Nature 411: 603–606.
110. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, et al. (2007) Epithelial
NEMO links innate immunity to chronic intestinal inﬂammation. Nature
446: 557–561.
111. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, et al. (2007) NALP1
in vitiligo-associated multiple autoimmune disease. N Engl J Med 356:
1216–1225.
112. Bestor TH, Bourc’his D (2006) Genetics and epigenetics of hydatidiform
moles. Nat Genet 38: 274–276.
113. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, et al. (2006) Mutations
in NALP7 cause recurrent hydatidiform moles and reproductive wastage
in humans. Nat Genet 38: 300–302.
114. Djuric U, El-Maarri O, Lamb B, Kuick R, Seoud M, et al. (2006) Familial
molar tissues due to mutations in the inﬂammatory gene, NALP7, have
normal postzygotic DNA methylation. Hum Genet 120: 390–395.
115. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T (2005) PYPAF3, a
PYRIN-containing APAF-1-like protein, is a feedback regulator of
caspase-1-dependent interleukin-1beta secretion. J Biol Chem 280: 21720–
21725.
116. Okada K, Hirota E, Mizutani Y, Fujioka T, Shuin T, et al. (2004) Oncogenic
role of NALP7 in testicular seminomas. Cancer Sci 95: 949–954.
PLoS Pathogens | www.plospathogens.org December 2007 | Volume 3 | Issue 12 | e152 1836